Litigation Details for Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. (D. Del. 2020)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. (D. Del. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-03-24 |
Court | District Court, D. Delaware | Date Terminated | 2022-02-08 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Parties | LUPIN LIMITED | ||
Patents | 8,101,659; 8,404,744; 8,796,331; 8,877,938; 9,388,134 | ||
Attorneys | Catherine R. Gourash | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A.
Details for Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-04-27 | 12 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,404,744 . (Cottrell, Frederick…2020 9 February 2022 1:20-cv-00415 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2022-06-07 | 123 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 8,796,331; 8,877,938…2020 9 February 2022 1:20-cv-00415 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |